Your browser doesn't support javascript.
loading
Post-COVID-19 Condition.
Nalbandian, Ani; Desai, Amar D; Wan, Elaine Y.
Afiliação
  • Nalbandian A; Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA; email: an2558@cumc.columbia.edu, eyw2003@cumc.columbia.edu.
  • Desai AD; Rutgers New Jersey Medical School, Newark, New Jersey, USA; email: add130@njms.rutgers.edu.
  • Wan EY; Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA; email: an2558@cumc.columbia.edu, eyw2003@cumc.columbia.edu.
Annu Rev Med ; 74: 55-64, 2023 01 27.
Article em En | MEDLINE | ID: mdl-35914765
ABSTRACT
An estimated 10-15% of those infected with SARS-CoV-2 may have post-COVID-19 condition. Common lingering signs and symptoms include shortness of breath, fatigue, high heart rate, and memory and cognitive dysfunction even several months after infection, often impacting survivors' quality of life. The prevalence and duration of individual symptoms remain difficult to ascertain due to the lack of standardized research methods across various studies and limited patient follow-up in clinical studies. Nonetheless, data indicate post-COVID-19 condition may occur independent of acuity of initial infection, hospitalization status, age, or pre-existing comorbidities. Risk factors may include female sex and underlying respiratory or psychiatric disease. Supportive therapies to mitigate symptoms remain the mainstay of treatment. Reassuringly, most patients experience a reduction in symptoms by 1 year. The use of a universal case definition and shared research methods will allow for further clarity regarding the pervasiveness of this entity and its long-term health consequences.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Disfunção Cognitiva / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Annu Rev Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Disfunção Cognitiva / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Annu Rev Med Ano de publicação: 2023 Tipo de documento: Article